Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2007
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265344 Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265315 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality; p38 mediated diseases such as inflammation and VEGF mediated diseases such as angogenesis disorders
11/15/2007US20070265294 Formulations and methods for vascular permeability-related diseases or conditions
11/15/2007US20070265293 Opioid antagonists; lyophilization
11/15/2007US20070265289 2-Aminopyrimidine Derivative
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265285 Quinazolinone derivatives and their use as CB agonists
11/15/2007US20070265275 Treatment of Mastitis
11/15/2007US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265259 Proline Derivatives
11/15/2007US20070265239 Topically applicable anti-inflammatory O/W emulsions comprising pro-penetrating glycols
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070264417 Procyanidins; cleaning cocoa beans, heating unroasted cocoa nibs to loosen shells, winnowing the nibs from the shells, extracting with a polar solvent, a non-polar solvent, or a supercritical fluid
11/15/2007US20070264361 Composition for Suppressing Cyclooxygenase and/or 5-Lypoxygenase
11/15/2007US20070264270 Endometriosis markers
11/15/2007US20070264237 Use of Il-18 Binding Protein in Inflammations
11/15/2007US20070264195 Modulation of Activity of Neurotrophins
11/15/2007DE19544507B4 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations
11/15/2007CA2651128A1 Benzimidazole modulators of vr1
11/15/2007CA2650970A1 P38 map kinase inhibitors
11/15/2007CA2650553A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
11/15/2007CA2650423A1 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and paracetamol
11/15/2007CA2649813A1 A system for wireless transmission of measurement results intended to be used in a coupling device and a use of the system in a vehicle
11/15/2007CA2649459A1 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
11/14/2007EP1854793A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY
11/14/2007EP1854787A1 Novel cyclic compound having quinolylalkylthio group
11/14/2007EP1854480A2 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/14/2007EP1854470A1 Method of treating inflammation disorders using extracts of passion fruit
11/14/2007EP1854460A1 External plaster containing flurbiprofen
11/14/2007EP1853601A1 Non steroidal glucocorticoid receptor modulators
11/14/2007EP1853587A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/14/2007EP1853583A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/14/2007EP1853581A1 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
11/14/2007EP1853566A1 Cinnoline compounds and their use as liver x receptor modulators
11/14/2007EP1853284A1 Use of lactobacillus kefiranofaciens as a probiotic and a synbiotic
11/14/2007EP1853281A1 Analgesic and anti-inflammatory composition
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1581223B1 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
11/14/2007EP1565442B1 Pyridine derivatives as cb2 receptor modulators
11/14/2007EP1495018B1 Tricyclic thrombin receptor antagonists
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1370264B1 Nicotinic receptor agonists for the treatment of pulmonary inflammatory diseases
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007EP1254239B1 Mammalian secreted group iii phospholipase a2
11/14/2007EP1212086B1 Immunological tolerance-induction agent
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007CN101072509A Treatment and prevention of inflammatory disorders
11/14/2007CN101069712A Medicine composition for treating soft tissue injury and preparing method
11/14/2007CN101069708A Chinese medicine composition for treating plegmon, tenosynovitis and preparing method
11/14/2007CN101069699A Bone-tonifying pills for promoting bone growth
11/14/2007CN101069698A Method for preparing termite fugus gardens extract and use thereof
11/14/2007CN101069681A Injection containing burufen
11/14/2007CN101069679A Composition for making womb relaxation and method for relieving dysmenorrhea
11/14/2007CN101069676A Method for preparing brufen soft capsule
11/14/2007CN101069555A Kudzuvine root areca and making method
11/14/2007CN100348615C Gene of restraining activation NF-kB and NFAT, and coded polypeptide
11/14/2007CN100348611C Method for producing soybean trypsin inhibitor concentration
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348584C 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
11/14/2007CN100348583C Novel enantiomer of tetra hydrogen isoquinoline derivative and officinal salt, preparation and pharmaceutical composition thereof
11/14/2007CN100348239C Chinese traditional medicine for curing soft tissue pains and process for preparing the same
11/14/2007CN100348231C Medicine composition for resisting exogenous cold and high fever, and its preparing method
11/14/2007CN100348208C Method for preparing Chinese medicinal preparation of whiteback thundergodvine by water decoction alcohol precipitation
11/14/2007CN100348181C Water-dispersive nano-grade ibuprofen injecta and preparing method
11/14/2007CN100348170C Yitongshu drop pill for treating pain and its preparation method
11/14/2007CN100348169C Saussurea involucrata drop pill and its preparation method
11/14/2007CN100348168C Externally-used pain-relieving spray
11/13/2007US7294753 Method for preparing anti-MIF antibodies
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294718 Synthesis of a 4-methylthiazole-4(S)-carboxylic acid compound
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294473 Methods of identifying substances that interact with JTT-1 protein
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007US7294352 Matrix protein composition for treating inflammation
11/13/2007US7294345 Otorhinological delivery device
11/13/2007US7294339 Method for treating allodynia by peripheral administration of a neurotoxin
11/13/2007US7294337 Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies
11/13/2007CA2283637C Upar mimicking peptide
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007127475A2 Pyridazines for demyelinating diseases and neuropathic pain
11/08/2007WO2007126871A1 P38 inhibitors and methods of use thereof
11/08/2007WO2007126771A2 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
11/08/2007WO2007126439A2 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
11/08/2007WO2007126221A1 Composition comprising ursolic acid and oleanolic acid for improving and treating arthritis
11/08/2007WO2007126063A1 Granulated particle, tablet and method for producing granulated particle
11/08/2007WO2007125203A1 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials.
11/08/2007WO2007125197A1 Novel imidazole derivatives, preparation and user thereof as medicine
11/08/2007WO2007124832A1 4-amino-2,6-dimethylphenol compound, process for its preparation and pharmaceutical composition comprising the same
11/08/2007WO2007124541A1 Cox-2 inhibitor